Baseline findings of the population-based, randomized, multifaceted Danish cardiovascular screening trial (DANCAVAS) of men aged 65-74 years.
Jes Sanddal LindholtL M RasmussenRikke SøgaardJ LambrechtsenF H SteffensenL FrostK EgstrupG UrbonavicieneM BuskM H OlsenJ HallasA C DiederichsenPublished in: The British journal of surgery (2019)
Multifaceted cardiovascular screening is feasible and may optimize cardiovascular disease prevention in men aged 65-74 years. Uptake is lower than in aortic aneurysm screening.